XML 32 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Borrowings
9 Months Ended
Apr. 29, 2017
Debt Disclosure [Abstract]  
Borrowings
Borrowings
(a)
Short-Term Debt
The following table summarizes the Company’s short-term debt (in millions, except percentages):
 
April 29, 2017
 
July 30, 2016
 
Amount
 
Effective Rate
 
Amount
 
Effective Rate
Current portion of long-term debt
$
2,248

 
1.58
%
 
$
4,159

 
0.97
%
Commercial paper
2,000

 
0.88
%
 

 

Other notes and borrowings

 

 
1

 
2.08
%
Total short-term debt
$
4,248

 
 
 
$
4,160

 


The effective interest rate on the current portion of long-term debt includes the impact of interest rate swaps, as discussed further in "(b) Long-Term Debt." Other notes and borrowings consist of the short-term portion of secured borrowings associated with customer financing arrangements. These notes and credit facilities were subject to various terms and foreign currency market interest rates pursuant to individual financial arrangements between the financing institution and the applicable foreign subsidiary.
Effective March 31, 2017, the Company increased its borrowing capacity under its existing commercial paper program from $3.0 billion to $10.0 billion. The Company uses the proceeds from the issuance of commercial paper notes for general corporate purposes. The Company had $2.0 billion and no commercial paper notes outstanding as of April 29, 2017 and July 30, 2016, respectively.
(b)
Long-Term Debt
The following table summarizes the Company’s long-term debt (in millions, except percentages):
 
 
 
April 29, 2017
 
July 30, 2016
 
Maturity Date
 
Amount
 
Effective Rate
 
Amount
 
Effective Rate
Senior notes:
 
 
 
 
 
 
 
 
 
Floating-rate notes:
 
 
 
 
 
 
 
 
 
Three-month LIBOR plus 0.28%
March 3, 2017
(1)
$

 
 
$
1,000

 
1.03%
Three-month LIBOR plus 0.60%
February 21, 2018
 
1,000

 
1.72%
 
1,000

 
1.32%
Three-month LIBOR plus 0.31%
June 15, 2018
 
900

 
1.51%
 
900

 
1.03%
Three-month LIBOR plus 0.50%
March 1, 2019
 
500

 
1.62%
 
500

 
1.23%
Three-month LIBOR plus 0.34%
September 20, 2019
(2)
500

 
1.53%
 

 
Fixed-rate notes:
 
 
 
 
 
 
 
 
 
1.10%
March 3, 2017
(1)

 
 
2,400

 
0.87%
3.15%
March 14, 2017
(1)

 
 
750

 
1.22%
1.40%
February 28, 2018
 
1,250

 
1.47%
 
1,250

 
1.47%
1.65%
June 15, 2018
 
1,600

 
1.72%
 
1,600

 
1.72%
4.95%
February 15, 2019
 
2,000

 
4.90%
 
2,000

 
4.76%
1.60%
February 28, 2019
 
1,000

 
1.67%
 
1,000

 
1.67%
2.125%
March 1, 2019
 
1,750

 
1.60%
 
1,750

 
1.08%
1.40%
September 20, 2019
(2)
1,500

 
1.48%
 

 
4.45%
January 15, 2020
 
2,500

 
3.66%
 
2,500

 
3.25%
2.45%
June 15, 2020
 
1,500

 
2.54%
 
1,500

 
2.54%
2.20%
February 28, 2021
 
2,500

 
2.30%
 
2,500

 
2.30%
2.90%
March 4, 2021
 
500

 
1.76%
 
500

 
1.24%
1.85%
September 20, 2021
(2)
2,000

 
1.90%
 

 
3.00%
June 15, 2022
 
500

 
2.03%
 
500

 
1.51%
2.60%
February 28, 2023
 
500

 
2.68%
 
500

 
2.68%
2.20%
September 20, 2023
(2)
750

 
2.27%
 

 
3.625%
March 4, 2024
 
1,000

 
1.88%
 
1,000

 
1.36%
3.50%
June 15, 2025
 
500

 
2.19%
 
500

 
1.67%
2.95%
February 28, 2026
 
750

 
3.01%
 
750

 
3.01%
2.50%
September 20, 2026
(2)
1,500

 
2.55%
 

 
5.90%
February 15, 2039
 
2,000

 
6.11%
 
2,000

 
6.11%
5.50%
January 15, 2040
 
2,000

 
5.67%
 
2,000

 
5.67%
Total
 
 
30,500

 
 
 
28,400

 
 
Unaccreted discount/issuance costs
 
 
(140
)
 
 
 
(137
)
 
 
Hedge accounting fair value adjustments
 
 
110

 
 
 
379

 
 
Total
 
 
$
30,470

 
 
 
$
28,642

 
 
 
 
 
 
 
 
 
 
 
 
Reported as:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
 
$
2,248

 
 
 
$
4,159

 
 
Long-term debt
 
 
28,222

 
 
 
24,483

 
 
Total
 
 
$
30,470

 
 
 
$
28,642

 
 
(1) In March 2017, the Company repaid senior notes with an aggregate principal amount of $4.15 billion upon maturity.
(2) In September 2016, the Company issued senior notes for an aggregate principal amount of $6.25 billion.

To achieve its interest rate risk management objectives, the Company entered into interest rate swaps in prior periods with an aggregate notional amount of $6.8 billion designated as fair value hedges of certain of its fixed-rate senior notes. In effect, these swaps convert the fixed interest rates of the fixed-rate notes to floating interest rates based on the London InterBank Offered Rate ("LIBOR"). The gains and losses related to changes in the fair value of the interest rate swaps substantially offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. For additional information, see Note 11.
The effective rates for the fixed-rate debt include the interest on the notes, the accretion of the discount, the issuance costs, and, if applicable, adjustments related to hedging. Interest is payable semiannually on each class of the senior fixed-rate notes and payable quarterly on the floating-rate notes. Each of the senior fixed-rate notes is redeemable by the Company at any time, subject to a make-whole premium. 
The senior notes rank at par with the commercial paper notes that have been issued pursuant to the Company’s short-term debt financing program, as discussed above under “(a) Short-Term Debt.” As of April 29, 2017, the Company was in compliance with all debt covenants.
As of April 29, 2017, future principal payments for long-term debt, including the current portion, are summarized as follows (in millions):
Fiscal Year
Amount
2017 (remaining three months)
$

2018
4,750

2019
5,250

2020
6,000

2021
3,000

Thereafter
11,500

Total
$
30,500


(c)
Credit Facilities
On May 15, 2015, the Company entered into a credit agreement with certain institutional lenders that provides for a $3.0 billion unsecured revolving credit facility that is scheduled to expire on May 15, 2020. Any advances under the credit agreement will accrue interest at rates that are equal to, based on certain conditions, either (i) the highest of (a) the Federal Funds rate plus 0.50%, (b) Bank of America’s “prime rate” as announced from time to time, or (c) LIBOR, or a comparable or successor rate that is approved by the Administrative Agent (“Eurocurrency Rate”), for an interest period of one-month plus 1.00%, or (ii) the Eurocurrency Rate, plus a margin that is based on the Company’s senior debt credit ratings as published by Standard & Poor’s Financial Services, LLC and Moody’s Investors Service, Inc., provided that in no event will the Eurocurrency Rate be less than zero. The Company may also, upon the agreement of either the then-existing lenders or additional lenders not currently parties to the agreement, increase the commitments under the credit facility by up to an additional $2.0 billion and/or extend the expiration date of the credit facility up to May 15, 2022.
In addition, on March 30, 2017, the Company entered into a 364-Day credit agreement with certain institutional lenders that provides for a $2.0 billion unsecured revolving credit facility that is scheduled to expire on March 29, 2018. The credit agreement also provides the Company with the option to, for a fee, convert any borrowing outstanding thereunder on March 29, 2018 to a term loan maturing no later than March 29, 2019. The interest rate applicable to outstanding balances under the credit agreement will be based on either (i) the higher of (a) the rates on overnight Federal Funds transactions with members of the Federal Reserve System (i.e., Federal Funds rate) plus 0.50%, (b) Bank of America’s “prime rate” as announced from time to time or (c) LIBOR for an interest period of one month plus 1.00%, or (ii) LIBOR plus a margin that is based on the Company's senior debt credit ratings as published by S&P Global Rating, a business unit of Standard & Poor’s Financial Services LLC, and Moody’s Investors Service, Inc.
These credit agreements require that the Company comply with certain covenants, including that the Company maintains an interest coverage ratio as defined in these agreements. As of April 29, 2017, the Company was in compliance with the required interest coverage ratios and the other covenants, and the Company had not borrowed any funds under these credit facilities.